Aurora-A/ERK1/2/mTOR axis promotes tumor progression in triple-negative breast cancer and dual-targeting Aurora-A/mTOR shows synthetic lethality

Triple-negative breast cancer (TNBC), defined as a tumor subtype that lacks ER, PR, and HER2, shows a poor prognosis due to its aggressive tumor biology and limited treatment options. Deregulation of Aurora kinase A (Aur-A), a member of the mitotic serine/threonine Aurora kinase family, and overacti...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Wenfeng, Xia, Ding, Li, Zhangyun, Zhou, Tao, Chen, Tingting, Wu, Zhengping, Zhou, Weihua, Li, Zilun, Li, Longkun, Xu, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6690898/
https://www.ncbi.nlm.nih.gov/pubmed/31406104
http://dx.doi.org/10.1038/s41419-019-1855-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6690898/
https://www.ncbi.nlm.nih.gov/pubmed/31406104
http://dx.doi.org/10.1038/s41419-019-1855-z

Ejemplares similares